- This guideline is relevant to women without a personal history of breast cancer (BC) who are at increased risk of developing the disease.
The digital version of the American Society of Clinical Oncology Breast Cancer – Use of Endocrine Therapy for Risk Reduction GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:
For individual use only; contact us for group and site licenses.
The Breast Cancer – Use of Endocrine Therapy for Risk Reduction Pocket Guide is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains graded recommendations for the use of selective estrogen receptor modulators and aromatase inhibitors to reduce the risk of developing breast cancer, including a table of adverse effects from treatment.
To get started, log in or create your free account Create Account